Skip to content

VRTX

Vertex Pharmaceuticals Incorporated

Stock

$504.73−2.01 (−0.40%)Close Oct 2, 2026

Adjusted price

+23.45% total return, past year

Key statistics

Market cap
$127.9B
P/E (TTM)
29.4
52-week range
$402.90$557.96
Beta (5Y monthly)
0.28
Median dollar volume
$459M
Shares outstanding
253.5M
Revenue, last 12 months
$12.6B
First close
Jul 24, 1991

Total

1M
−9.3%
YTD
+11.3%
1Y
+23.5%

Per year

3Y
+13.2%
5Y
+22.9%
10Y
+19.2%
20Y
+14.4%
Since 1991
+14.4%

Financials

Revenue

$12.6BLast 12 months

Gross profit

$10.8BLast 12 months

Operating income

$4.8BLast 12 months

Net income

$4.4BLast 12 months

EPS

$17.18Last 12 months

Free cash flow

$3.8BLast 12 months

Annual returns

1991 from Jul 24 · 2026 through Oct 2